2008
DOI: 10.1016/j.ijantimicag.2007.03.014
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 26 publications
0
12
0
Order By: Relevance
“…The results of this study slightly differed from other data on European and North American antibiotic-resistant clinical isolates that were phenotypically characterized [1315]. In a recent study, the in vitro activity of tigecycline against 38 MRSA and the correlation of this activity with their resistance gene content were determined [16]. Tigecycline demonstrated good activity against MRSA, with MIC 50 and MIC 90 values of 0.12 and 0.25 μg/ml, respectively.…”
Section: Resultsmentioning
confidence: 61%
“…The results of this study slightly differed from other data on European and North American antibiotic-resistant clinical isolates that were phenotypically characterized [1315]. In a recent study, the in vitro activity of tigecycline against 38 MRSA and the correlation of this activity with their resistance gene content were determined [16]. Tigecycline demonstrated good activity against MRSA, with MIC 50 and MIC 90 values of 0.12 and 0.25 μg/ml, respectively.…”
Section: Resultsmentioning
confidence: 61%
“…Susceptibility to erythromycin, azithromycin, clindamycin and tetracycline was performed by the broth dilution method, as recommended by the Clinical and Laboratory Standards Institute (Standard, 2006). The resistance genes – erm, mef , and tet – were studied by PCR using previously published primers and protocols, followed by sequencing (Borbone et al , 2007).…”
Section: Methodsmentioning
confidence: 99%
“…Tigecycline has potent in vitro activity against a wide range of Gram‐positive and Gram‐negative bacteria, including MRSA and methicillin‐resistant Staphylococcus epidermidis [259–268].…”
Section: Tigecyclinementioning
confidence: 99%